121 related articles for article (PubMed ID: 19826047)
21. Epigenetics of myelodysplastic syndromes.
Itzykson R; Fenaux P
Leukemia; 2014 Mar; 28(3):497-506. PubMed ID: 24247656
[TBL] [Abstract][Full Text] [Related]
22. MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
Heinrichs S; Conover LF; Bueso-Ramos CE; Kilpivaara O; Stevenson K; Neuberg D; Loh ML; Wu WS; Rodig SJ; Garcia-Manero G; Kantarjian HM; Look AT
Elife; 2013 Jul; 2():e00825. PubMed ID: 23878725
[TBL] [Abstract][Full Text] [Related]
23. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
Jerez A; Gondek LP; Jankowska AM; Makishima H; Przychodzen B; Tiu RV; O'Keefe CL; Mohamedali AM; Batista D; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
J Clin Oncol; 2012 Apr; 30(12):1343-9. PubMed ID: 22370328
[TBL] [Abstract][Full Text] [Related]
24. Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS.
Gerds AT; Gooley TA; Estey EH; Appelbaum FR; Deeg HJ; Scott BL
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1211-8. PubMed ID: 22252125
[TBL] [Abstract][Full Text] [Related]
25. Histone methylation in myelodysplastic syndromes.
Wei Y; Gañán-Gómez I; Salazar-Dimicoli S; McCay SL; Garcia-Manero G
Epigenomics; 2011 Apr; 3(2):193-205. PubMed ID: 22122281
[TBL] [Abstract][Full Text] [Related]
26. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML.
Treppendahl MB; Qiu X; Søgaard A; Yang X; Nandrup-Bus C; Hother C; Andersen MK; Kjeldsen L; Möllgård L; Hellström-Lindberg E; Jendholm J; Porse BT; Jones PA; Liang G; Grønbæk K
Blood; 2012 Jan; 119(1):206-16. PubMed ID: 22058117
[TBL] [Abstract][Full Text] [Related]
27. Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.
Gong Y; Guo MZ; Ye ZJ; Zhang XL; Zhao YL; Yang YS
World J Gastroenterol; 2011 Jan; 17(4):526-33. PubMed ID: 21274384
[TBL] [Abstract][Full Text] [Related]
28. Unraveling the molecular pathophysiology of myelodysplastic syndromes.
Bejar R; Levine R; Ebert BL
J Clin Oncol; 2011 Feb; 29(5):504-15. PubMed ID: 21220588
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.
Chen TH; Kambal A; Krysiak K; Walshauser MA; Raju G; Tibbitts JF; Walter MJ
Blood; 2011 Feb; 117(5):1530-9. PubMed ID: 21123823
[TBL] [Abstract][Full Text] [Related]
30. Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.
Shih IeM; Chen L; Wang CC; Gu J; Davidson B; Cope L; Kurman RJ; Xuan J; Wang TL
Am J Obstet Gynecol; 2010 Dec; 203(6):584.e1-22. PubMed ID: 20965493
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the 5q- chromosome.
Nagarajan L
Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
[TBL] [Abstract][Full Text] [Related]
32. [Research progress on mechanism of MDS transformation into AML].
Wang LL; Gao C; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):254-9. PubMed ID: 21362264
[TBL] [Abstract][Full Text] [Related]
33. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
Ye Y; McDevitt MA; Guo M; Zhang W; Galm O; Gore SD; Karp JE; Maciejewski JP; Kowalski J; Tsai HL; Gondek LP; Tsai HC; Wang X; Hooker C; Smith BD; Carraway HE; Herman JG
Cancer Res; 2009 Nov; 69(21):8482-90. PubMed ID: 19826047
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
35. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
[TBL] [Abstract][Full Text] [Related]
36. Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome.
Qian J; Chen XX; Qian W; Yang J; Wen XM; Ma JC; Deng ZQ; Qian Z; Zhang YY; Lin J
Clin Chem Lab Med; 2014 Dec; 52(12):1859-65. PubMed ID: 25153418
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
